Target intelligence / Profile preview

Conserved viral genomic sequences in hemorrhagic fever viruses

Molecular classification
Nucleic acid, Viral RNA, Viral DNA
01

Overview

Conserved viral genomic sequences in hemorrhagic fever viruses refer to highly stable and essential segments of the viral genome, typically RNA, that are shared across different strains or species of viruses causing hemorrhagic fevers, such as Filoviridae (Ebola, Marburg) and Arenaviridae (Lassa) (Source: PubMed, PMID: 20729952). These sequences often reside in the 5' or 3' untranslated regions (UTRs) or within critical genes like the L-polymerase, where they serve as promoters or signals for replication, transcription, and packaging (Source: UniProt, Viral Genome Organization). Because these regions are vital for the viral life cycle, they are less prone to mutation, making them ideal targets for broad-spectrum or pan-viral therapeutic interventions. Drugs targeting these sequences, such as antisense oligonucleotides (ASOs) like AVI-6002 and small interfering RNAs (siRNAs) like TKM-Ebola, work by binding to the viral genome to trigger degradation or physically block the machinery required for protein synthesis and genome copying (Source: Nature Medicine, doi:10.1038/nm.2202). This approach aims to provide a high barrier to resistance and potentially treat multiple related viral threats with a single platform, though challenges remain regarding delivery and potential off-target effects on host RNA (Source: NIH, Viral Hemorrhagic Fevers Research).

Other names
Conserved viral RNAVHF genomic motifsPan-viral conserved sequencesViral regulatory elementsConserved non-coding regions
02

Mechanism of action

Sequence-specific hybridization to viral RNA leading to enzymatic degradation (via RNase H or RISC) or steric blockade of viral replication and translation machinery.

03

Biological functions

Viral replicationViral transcriptionViral translationGenome packagingViral assemblyViral genome stability
04

Disease associations

InfectionViral hemorrhagic feverEbola virus diseaseMarburg virus diseaseLassa feverCrimean-Congo hemorrhagic fever
05

Safety considerations

Off-target hybridization to host mRNAInnate immune activation via Toll-like receptors (TLR7/8)Delivery-related toxicity from lipid nanoparticlesDevelopment of viral escape mutantsHepatotoxicity
06

Interacting drugs

AVI-6002

2 more in the full profile.

07

Biomarkers

Viral RNA titer (RT-qPCR)Serum aspartate aminotransferase (AST)Serum alanine aminotransferase (ALT)Prothrombin time (PT)Platelet count

Beyond the preview

Go deeper on Conserved viral genomic sequences in hemorrhagic fever viruses.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Conserved viral genomic sequences in hemorrhagic fever viruses.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call